(DYAX:Consolidated Issue listed on NASDAQ Global Market)
Mary Ann Gray Ph.D.
Lead Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee, Dyax Corp.
|Age||Total Calculated Compensation||This person is connected to 47 board members in 4 different organizations across 8 different industries.|
See Board Relationships
Dr. Mary Ann Gray, Ph.D. is the Founder of Gray Strategic Advisors LLC and serves as its President. Dr. Gray has extensive experience in the biotechnology and pharmaceutical industries. She has over twelve years of experience as a scientist in academia and industry. She served as Senior Analyst and Portfolio Manager for Federated Equity Funds - Federated Kaufmann Fund from 1999 to 2003. Dr. Gray spent three and a half years with the Federated Kaufmann Fund focusing on ...
55 Network DrivePhone: 617-225-2500
Burlington, Massachusetts 01803
Board Members Memberships*
Former Director and Member of Nominating Committee
Lead Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
Independent Director, Chairperson of Audit Committee and Member of Compensation Committee
Former Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
Director and Member of Compensation Committee
Director and Chairman of Audit Committee
The University of Vermont
University of South Carolina
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Ron Cohen M.D.||Founder, Chief Executive Officer, President and Director|
Acorda Therapeutics, Inc.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|$552.5K||Compensation as of Fiscal Year 2014.|